InsidersTradesSigma
Track the CanSino Biologics Inc. share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, CanSino Biologics Inc. has logged 3 public disclosures. Market capitalisation: €5.8bn. The latest transaction was filed on 30 March 2026 (Purchase). Among the most active insiders: Chao Shou Bai. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
康希诺生物股份公司是一家专注于创新疫苗和疗法开发的生物制药公司。该公司在香港证券交易所上市，股票代码为XHKG。